Top

Clinical and Translational Oncology

Published in:

01-03-2001 | Revisiones

Optimal treatment for poor prognosis isolated colorectal carcinoma liver metastases. Rationality for prospective neoadjuvant clinical trials

Authors: Joan Maurel Santasusana, Noemí Reguart Aransay

Published in: Clinical and Translational Oncology | Issue 2/2001

Title: Optimal treatment for poor prognosis isolated colorectal carcinoma liver metastases. Rationality for prospective neoadjuvant clinical trials
Authors: Joan Maurel Santasusana
Noemí Reguart Aransay
Publication date: 01-03-2001
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 2/2001
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/BF02711457

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2001

Anemia hemolítica microangiopática y metástasis cardíaca por carcinoma de cabeza y cuello

Polymerase chain reaction and DNA sequencing

Quality of life in breast cancer patients assessed using the EORTC questionnaires

Situación de la braquiterapia en España. Análisis de complejidad y tiempos de preparación y tratamiento

Información

Radioquimioterapia complementaria a cirugía radical en el adenocarcinoma de recto

Keynote webinar | Spotlight on antibody–drug conjugates in cancer